Highlights & Basics
- Short bowel syndrome typically presents as a consequence of extensive bowel resection.
- The intestine may adapt over time to be more efficient at nutrient absorption; the extent of adaptation determines the extent of recovery.
- Treatment and prognosis are dependent on the length, health, and anatomy of the remaining bowel.
- Management includes electrolyte and fluid replacement, provision of adequate macronutrients, and prevention and treatment of micronutrient deficiencies during intestinal adaptation.
- Primary anastomosis of residual small bowel to colon, when possible, is the most important surgical procedure to reduce the need for parenteral nutrition (PN).
Quick Reference
History & Exam
Key Factors
Other Factors
Diagnostics Tests
Treatment Options
Definition
Epidemiology
Etiology
Pathophysiology
Citations
Pironi L, Arends J, Baxter J, et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr. 2015 Apr;34(2):171-80.[Abstract][Full Text]
Cuerda C, Pironi L, Arends J, et al. ESPEN practical guideline: clinical nutrition in chronic intestinal failure. Clin Nutr. 2021 Sep;40(9):5196-220.[Abstract][Full Text]
Buchman AL. Short bowel syndrome. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's gastrointestinal and liver disease. 11th ed. Philadelphia, PA: Saunders; 2020.
Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003 Apr;124(4):1111-34.[Abstract][Full Text]
Nightingale JM, Lennard-Jones JE, Gertner DJ, et al. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gallstones in patients with a short bowel. Gut. 1992 Nov;33(11):1493-7.[Abstract]
1. Pironi L, Arends J, Baxter J, et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr. 2015 Apr;34(2):171-80.[Abstract][Full Text]
2. Cuerda C, Pironi L, Arends J, et al. ESPEN practical guideline: clinical nutrition in chronic intestinal failure. Clin Nutr. 2021 Sep;40(9):5196-220.[Abstract][Full Text]
3. Capriati T, Mosca A, Alterio T, et al. To wean or not to wean: the role of autologous reconstructive surgery in the natural history of pediatric short bowel syndrome on behalf of Italian Society for Gastroenterology, Hepatology and Nutrition (SIGENP). Nutrients. 2020 Jul 18;12(7):2136.[Abstract][Full Text]
4. Massironi S, Cavalcoli F, Rausa E, et al. Understanding short bowel syndrome: current status and future perspectives. Dig Liver Dis. 2020 Mar;52(3):253-61.[Abstract][Full Text]
5. Pohju AK, Pakarinen MP, Sipponen TM. Intestinal failure in Finland: prevalence and characteristics of an adult patient population. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(12):1505-10.[Abstract][Full Text]
6. Oley Foundation. North American home parenteral and enteral nutrition patient registry: annual report with outcome profiles 1985-1992. 1994 [internet publication].[Full Text]
7. Cole CR, Hansen NI, Higgins RD, et al; Eunice Kennedy Shriver NICHD Neonatal Research Network. Very low birth weight preterm infants with surgical short bowel syndrome: incidence, morbidity and mortality, and growth outcomes at 18 to 22 months. Pediatrics. 2008 Sep;122(3):e573-82.[Abstract][Full Text]
8. Salvia G, Guarino A, Terrin G, et al; Working Group on Neonatal Gastroenterology of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition. Neonatal onset intestinal failure: an Italian multicenter study. J Pediatr. 2008 Nov;153(5):674-6.[Abstract]
9. Chandra R, Kesavan A. Current treatment paradigms in pediatric short bowel syndrome. Clin J Gastroenterol. 2018 Apr;11(2):103-12.[Abstract][Full Text]
10. Buchman AL. Short bowel syndrome. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's gastrointestinal and liver disease. 11th ed. Philadelphia, PA: Saunders; 2020.
11. Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003 Apr;124(4):1111-34.[Abstract][Full Text]
12. Borgstrom B, Dahlqvist A, Lundh G, et al. Studies of intestinal digestion and absorption in the human. J Clin Invest. 1957 Oct;36(10):1521-36.[Abstract][Full Text]
13. Nightingale JM, Lennard-Jones JE, Walker ER, et al. Jejunal efflux in short bowel syndrome. Lancet. 1990 Sep 29;336(8718):765-8.[Abstract]
14. Andersson H, Bosaeus I, Brummer RJ, et al. Nutritional and metabolic consequences of extensive bowel resection. Dig Dis. 1986;4(4):193-202.[Abstract]
15. Andersson H. Effects of a fat-reduced diet on the faecal excretion of radioactivity following administration of 14C-cholic acid and on the duodenal concentration of bile salts in patients with ileal disease. Nutr Metab. 1976;20(4):254-63.[Abstract]
16. Jeppesen PB, Hartmann B, Hansen BS, et al. Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure. Gut. 1999 Oct;45(4):559-63.[Abstract][Full Text]
17. Messing B, Crenn P, Beau P, et al. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology. 1999 Nov;117(5):1043-50.[Abstract]
18. Carbonnel F, Cosnes J, Chevret S, et al. The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr. 1996 Jul-Aug;20(4):275-80.[Abstract]
19. Nightingale JM, Lennard-Jones JE, Gertner DJ, et al. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gallstones in patients with a short bowel. Gut. 1992 Nov;33(11):1493-7.[Abstract]
20. Staun M, Tjellesen L, Thale M, et al. Bone mineral content in patients on home parenteral nutrition. Clin Nutr. 1994 Dec;13(6):351-5.[Abstract]
21. Nightingale JM, Lennard-Jones JE, Gertner DJ, et al. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gallstones in patients with a short bowel. Gut. 1992 Nov;33(11):1493-7.[Abstract]
22. Ziegler TR, Cole CR. Small bowel bacterial overgrowth in adults: a potential contributor to intestinal failure. Curr Gastroenterol Rep. 2007 Dec;9(6):463-7.[Abstract]
23. Nordgaard I, Hansen BS, Mortensen PB. Colon as a digestive organ in patients with short bowel. Lancet. 1994 Feb 12;343(8894):373-6.[Abstract]
24. Jeppesen PB, Gilroy R, Pertkiewicz M, et al. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut. 2011 Jul;60(7):902-14.[Abstract][Full Text]
25. Jeppesen PB, Pertkiewicz M, Messing B, et al. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology. 2012;143:1473-1481;e3.[Abstract][Full Text]
26. Orhan A, Gögenur I, Kissow H. The intestinotrophic effects of glucagon-like peptide-2 in relation to intestinal neoplasia. J Clin Endocrinol Metab. 2018 Aug 1;103(8):2827-2837.[Abstract][Full Text]
27. Chang MI, Puder M, Gura KM. The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD). Nutrients. 2012 Nov 27;4(12):1828-50.[Abstract][Full Text]
28. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics. 2008 Mar;121(3):e678-86.[Abstract][Full Text]
29. Devine RM, Kelly KA. Surgical therapy of the short bowel syndrome. Gastroenterol Clin North Am. 1989;18:603-618.[Abstract]
30. Bianchi A. Longitudinal intestinal lengthening and tailoring: results in 20 children. J R Soc Med. 1997;90:429-432.[Abstract][Full Text]
31. Kim HB, Fauza D, Garza J, et al. Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure. J Pediatr Surg. 2003 Mar;38(3):425-9.[Abstract]
32. Pfeiffer A, Schmidt T, Kaess H. The role of osmolality in the absorption of a nutrient solution. Aliment Pharmacol Ther. 1998 Mar;12(3):281-6.[Abstract][Full Text]
33. Buchman AL. Etiology and initial management of short bowel syndrome. Gastroenterology. 2006 Feb;130(2 suppl 1):S5-S15.[Abstract]
34. Marteau P, Messing B, Arrigoni E, et al. Do patients with short-bowel syndrome need a lactose-free diet? Nutrition. 1997 Jan;13(1):13-6.[Abstract]
35. McIntyre PB, Fitchew M, Lennard-Jones JE. Patients with a high jejunostomy do not need a special diet. Gastroenterology. 1986 Jul;91(1):25-33.[Abstract]
36. Levy E, Frileux P, Sandrucci S, et al. Continuous enteral nutrition during the early adaptive stage of the short bowel syndrome. Br J Surg. 1988 Jun;75(6):549-53.[Abstract]
37. Windsor CW, Fejfar J, Woodward DA. Gastric secretion after massive small bowel resection. Gut. 1969 Oct;10(10):779-86.[Abstract]
38. Williams NS, Evans P, King RF. Gastric acid secretion and gastrin production in the short bowel syndrome. Gut. 1985 Sep;26(9):914-9.[Abstract][Full Text]
39. Jeppesen PB, Staun M, Tjellesen L, et al. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection. Gut. 1998 Dec;43(6):763-9.[Abstract][Full Text]
40. Jacobsen O, Ladefoged K, Stage JG, et al. Effects of cimetidine on jejunostomy effluents in patients with severe short-bowel syndrome. Scand J Gastroenterol. 1986 Sep;21(7):824-8.[Abstract]
41. Nightingale JM, Walker ER, Farthing MJ, et al. Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther. 1991 Aug;5(4):405-12.[Abstract]
42. O'Keefe SJ, Peterson ME, Fleming CR. Octreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndrome. J Parenter Enter Nutr. 1994 Jan-Feb;18(1):26-34.[Abstract]
43. Niv Y, Charash B, Sperber AD, et al. Effect of octreotide on gastrostomy, duodenostomy, and cholecystostomy effluents: a physiologic study of fluid and electrolyte balance. Am J Gastroenterol. 1997 Nov;92(11):2107-11.[Abstract]
44. Buchman AL, Fryer J, Wallin A, et al. Clonidine reduces diarrhea and sodium loss in patients with proximal jejunostomy: a controlled study. JPEN J Parenter Enteral Nutr. 2006;30:487-491.[Abstract]
45. American Gastroenterological Association. American Gastroenterological Association medical position statement: short bowel syndrome and intestinal transplantation. Gastroenterology. 2003 Apr;124(4):1105-10.[Abstract][Full Text]
46. Pironi L, Boeykens K, Bozzetti F, et al. ESPEN guideline on home parenteral nutrition. Clin Nutr. 2020 Jun;39(6):1645-66.[Abstract][Full Text]
47. US Department of Health & Human Services. Organ Procurement and Transplantation Network. Intestine Kaplan-Meier patient survival rates for transplants performed: 2008 - 2015. May 2022 [internet publication].[Full Text]
48. Duro D, Kamin D, Duggan C. Overview of pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr. 2008 Aug;47(supp 1):S33-S36.[Abstract]
49. Messing B, Bories C, Kunstlinger F, et al. Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? Gastroenterology. 1983;84:1012-1019.[Abstract]
50. Buchman AL, Iyer K, Fryer J. Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology. 2006 Jan;43(1):9-19.[Abstract][Full Text]
51. Stegink LD, Den Besten L. Synthesis of cysteine from methionine in normal adult subjects: effect of route of alimentation. Science. 1972 Nov 3;178(4060):514-6.[Abstract]
52. Buchman AL, Naini BV, Spilker B. The differentiation of intestinal-failure-associated liver disease from nonalcoholic fatty liver and nonalcoholic steatohepatitis. Semin Liver Dis. 2017 Feb;37(1):33-44.[Abstract][Full Text]
53. Buchman AL. Short bowel syndrome. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's gastrointestinal and liver disease. 8th ed. Philadelphia, PA: Saunders; 2006.
54. Hudson M, Pocknee R, Mowat NA. D-lactic acidosis in short bowel syndrome: an examination of possible mechanisms. Q J Med. 1990 Feb;74(274):157-63.[Abstract]
